Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 5
2005 5
2006 4
2007 7
2008 3
2009 5
2010 9
2011 11
2012 14
2013 4
2014 14
2015 9
2016 9
2017 8
2018 18
2019 18
2020 25
2021 23
2022 13
2023 11
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Results by year

Filters applied: . Clear all
Page 1
Electrophilic warheads in covalent drug discovery: an overview.
Péczka N, Orgován Z, Ábrányi-Balogh P, Keserű GM. Péczka N, et al. Expert Opin Drug Discov. 2022 Apr;17(4):413-422. doi: 10.1080/17460441.2022.2034783. Epub 2022 Feb 6. Expert Opin Drug Discov. 2022. PMID: 35129005 Review.
Covalent fragment approaches targeting non-cysteine residues.
Csorba N, Ábrányi-Balogh P, Keserű GM. Csorba N, et al. Among authors: keseru gm. Trends Pharmacol Sci. 2023 Nov;44(11):802-816. doi: 10.1016/ Epub 2023 Sep 26. Trends Pharmacol Sci. 2023. PMID: 37770315 Free article. Review.
Expanding the medicinal chemistry synthetic toolbox.
Boström J, Brown DG, Young RJ, Keserü GM. Boström J, et al. Among authors: keseru gm. Nat Rev Drug Discov. 2018 Oct;17(10):709-727. doi: 10.1038/nrd.2018.116. Epub 2018 Aug 24. Nat Rev Drug Discov. 2018. PMID: 30140018 Review.
Covalent fragment libraries in drug discovery.
Keeley A, Petri L, Ábrányi-Balogh P, Keserű GM. Keeley A, et al. Among authors: keseru gm. Drug Discov Today. 2020 Jun;25(6):983-996. doi: 10.1016/j.drudis.2020.03.016. Epub 2020 Apr 13. Drug Discov Today. 2020. PMID: 32298798 Free article. Review.
Targeting STAT3 and STAT5 in Cancer.
de Araujo ED, Keserű GM, Gunning PT, Moriggl R. de Araujo ED, et al. Among authors: keseru gm. Cancers (Basel). 2020 Jul 22;12(8):2002. doi: 10.3390/cancers12082002. Cancers (Basel). 2020. PMID: 32707820 Free PMC article.
The G protein database, GproteinDb.
Pándy-Szekeres G, Esguerra M, Hauser AS, Caroli J, Munk C, Pilger S, Keserű GM, Kooistra AJ, Gloriam DE. Pándy-Szekeres G, et al. Among authors: keseru gm. Nucleic Acids Res. 2022 Jan 7;50(D1):D518-D525. doi: 10.1093/nar/gkab852. Nucleic Acids Res. 2022. PMID: 34570219 Free PMC article.
Structure-based β-secretase (BACE1) inhibitors.
Polgár T, Keseru GM. Polgár T, et al. Among authors: keseru gm. Curr Pharm Des. 2014;20(20):3373-9. doi: 10.2174/13816128113199990607. Curr Pharm Des. 2014. PMID: 23947643 Review.
Covalent Docking in Drug Discovery: Scope and Limitations.
Scarpino A, Ferenczy GG, Keserű GM. Scarpino A, et al. Among authors: keseru gm. Curr Pharm Des. 2020;26(44):5684-5699. doi: 10.2174/1381612824999201105164942. Curr Pharm Des. 2020. PMID: 33155894 Review.
201 results